Although there is consistent evidence across several animal studies that exercise plays a role in modulating the AD neuropathological hallmarks, Aβ and tau (Adlard, 2005; Koo et al., 2017; Jeong and Kang, 2018; Brown et al., 2019), the conclusions from human studies are less clear. The gene discussed is MAPT; the disease is Alzheimer disease.